Insider trading

Period: 120 months Stock: OFIX Plan: Not stated × + Add filter Clear all
Views & alerts

Save your view. Keep the filter you have built, and get an email when a new filing matches it. A free account does both.

When

Period

How far back the list reaches. Filings arrive days after the trade, so the newest rows always lag a little.

41 decisions over 120 months
Who

Role

The position the person holds at the company, read from the title on the filing. A chief executive who is also a director counts as the chief executive.

41 decisions over 120 months
The trade

Type of trade

Purchases, sales, or cluster buys: companies where 3 or more insiders bought within 30 days. The number beside each is what that choice would give.

41 decisions over 120 months
The trade

Minimum amount

Hides rows under this value. The amount is the shares traded times the price on the filing.

41 decisions over 120 months
The trade

Plan

  • Discretionary: they chose to sell that week.
  • Scheduled: a 10b5-1 plan fixed the sale months in advance, so the timing says nothing about what they knew.
  • Not stated: filed before the SEC added the box in April 2023, which is most of the older half of this database.
41 decisions over 120 months Remove this filter
The trade

Share of their own holding

How much of what they already held the trade moved. Selling a tenth of a stake is not the same act as selling all of it.

At least
41 decisions over 120 months
Ownership

What the chief executive holds

The value of the chief executive’s stock measured against base salary. The salary comes from the company’s own proxy. Companies with no figure are in neither direction.

41 decisions over 120 months
Stock
Insider
Type ?
Why it stands out
22 Nov 2021
Bought
$62.30K 2,000 at 31.15
8.0%
First buy on file
19 Nov 2021
Bought
$50.25K 1,660 at 30.27
26.4%
First buy on file
19 Nov 2021
DOUG RICE CFO
Bought
$42.07K 1,400 at 30.05
1.9%
First buy on file
18 Nov 2021
Bought
$52.00K 1,670 at 31.14
1.5%
First buy on file
18 Nov 2021
Elting Kimberley A. Chief Legal & Develop. Officer
Bought
$30.34K 1,000 at 30.34
2.2%
First buy on file
5 Jun 2020
Finegan Michael Chief Strategy Officer
Sold, plan not stated
$327.32K 8,750 at 37.41
15.4%
16 Mar 2020
Bought
$485.00K 20,000 at 24.25
14.8%
First buy on file
12 Mar 2020
Bought
$268.47K 10,000 at 26.85
28.1%
First buy on file
27 Feb 2020
Bought
$102.90K 2,900 at 35.48
7.5%
First buy on file
31 Oct 2019
Bought 3×
$845.31K 20,000 at 42.27
17.5%
First buy on file
28 Aug 2019
Sold, plan not stated
$295.87K 5,805 at 50.97
3.4%
13 Jun 2019
Sold, plan not stated 2×
$454.33K 8,890 at 51.11
5.4%
14 May 2019
Sold, plan not stated 2×
$572.96K 10,668 at 53.71
6.1%
17 Apr 2019
Sold, plan not stated 2×
$311.44K 5,949 at 52.35
3.3%
19 Feb 2019
Bianchi Davide President, Global Extremities
Sold, plan not stated
$1.57M 24,199 at 65.00
53.9%
Sold half or more
15 Feb 2019
Bianchi Davide President, Global Extremities
Sold, plan not stated
$13.07K 201 at 65.00
0.4%
15 Jan 2019
Sold, plan not stated
$160.00K 3,200 at 50.00
2.3%
14 Jan 2019
Sold, plan not stated
$90.66K 1,800 at 50.37
1.3%
5 Nov 2018
NIEMANN BRADLEY V. President of Global Spine
Sold, plan not stated
$23.85K 387 at 61.63
1.5%
2 Nov 2018
FAULSTICK LUKE T Director
Sold, plan not stated 4×
$515.91K 8,450 at 61.05
56.6%
Sold half or more
2 Nov 2018
Elting Kimberley A. Chief Legal & Admin Officer
Sold, plan not stated
$427.34K 7,000 at 61.05
30.8%
2 Nov 2018
DOUG RICE CFO
Sold, plan not stated 2×
$371.00K 6,057 at 61.25
18.7%
11 Oct 2018
DOUG RICE CFO
Sold, plan not stated
$219.75K 3,949 at 55.65
10.9%
5 Sep 2018
Sold, plan not stated
$132.55K 2,500 at 53.02
1.7%
7 Aug 2018
Sold, plan not stated 4×
$133.17K 2,500 at 53.27
1.6%
10 Jul 2018
Sold, plan not stated
$146.55K 2,500 at 58.62
1.8%
3 Jul 2018
NIEMANN BRADLEY V. President of Global Spine
Sold, plan not stated 2×
$641.44K 11,250 at 57.02
29.4%
20 Jun 2018
FUJIKAWA RAYMOND President Spine Fixation
Sold, plan not stated 2×
$1.94M 32,243 at 60.21
71.5%
Sold half or more
19 Jun 2018
Bianchi Davide President Extremity Fixation
Sold, plan not stated
$885.72K 14,762 at 60.00
26.4%
18 Jun 2018
Finegan Michael Chief Strategy Officer
Sold, plan not stated 2×
$1.76M 30,000 at 58.81
44.9%
14 Jun 2018
Sold, plan not stated
$144.86K 2,500 at 57.95
1.7%
3 May 2018
Bought
$519.72K 10,000 at 51.97
10.9%
First buy on file
11 Dec 2017
NIEMANN BRADLEY V. President Biostim
Sold, plan not stated
$288.86K 5,547 at 52.08
13.8%
28 Nov 2017
Sold, plan not stated
$267.40K 5,000 at 53.48
2.7%
6 Nov 2017
FAULSTICK LUKE T Director
Sold, plan not stated
$245.85K 4,800 at 51.22
38.3%
11 Sep 2017
DOUG RICE CFO
Sold, plan not stated
$363.69K 7,353 at 49.46
14.1%
11 Sep 2017
NIEMANN BRADLEY V. President Biostim
Sold, plan not stated
$343.93K 6,956 at 49.44
14.8%
21 Aug 2017
Sold, plan not stated
$131.46K 2,733 at 48.10
1.4%
10 Aug 2017
FUJIKAWA RAYMOND President Spine Fixation
Sold, plan not stated
$299.50K 6,364 at 47.06
17.0%
10 Nov 2016
Sold, plan not stated
$167.19K 4,538 at 36.84
3.0%
8 Nov 2016
Sold, plan not stated
$184.07K 5,000 at 36.81
3.2%
Showing 1–41 of 41.